EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis

Zezhou Shi, Min Zhou, Jingfang Zhai, Jie Sun, Xiaojing Wang

Archiv der Pharmazie · 2024-10 · 357 (10)

DOI: 10.1002/ardp.202400192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 03.07.2024. Verfasst von Zezhou Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Science…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Biological Products. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: Shandong Province Science and Technology Small and Medium Enterprises Innovation Ability Enhancement Project, "Chunhui Program" Cooperative scientific research project of Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease of unknown etiology. Currently, drugs used to treat IPF in clinical practice exhibit severe side effects and limitations. To address these issues, this paper discusses the therapeutic effects of preclinical targeted drugs (such as STAT3 and TGF‐β/Smad pathway inhibitors, chitinase inhibitors, PI3K and phosphodiesterase inhibitors, etc.) and natural products on IPF. Through a summary of current research progress, it is found that natural products possess multitarget effects, stable therapeutic efficacy, low side effects, and nondrug dependence. Furthermore, we discuss the significant prospects of natural product molecules in combating fibrosis by influencing the immune system, expecting that current analytical data will aid in the development of new drugs or the investigation of active ingredients in natural products for potential IPF treatments in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisBiological ProductsHumansAnimalsAntifibrotic Agents

Stichwörter der Autor:innen

idiopathic pulmonary fibrosismechanism of actionnatural productssignaling pathwaytreatment

Substanzen

Biological ProductsAntifibrotic Agents

Autor:innen und Institutionen

  • School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of Biotechnology Drugs (Shandong Academy of Medi…

Förderung

  • Shandong Province Science and Technology Small and Medium Enterprises Innovation Ability Enhancement Project
  • "Chunhui Program" Cooperative scientific research project of Ministry of Education

Zitieren

APA

Shi, Z., Zhou, M., Zhai, J., Sun, J., & Wang, X. (2024). Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis. Archiv der Pharmazie, 357(10). https://doi.org/10.1002/ardp.202400192

Vancouver

Shi Z, Zhou M, Zhai J, Sun J, Wang X. Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis. Archiv der Pharmazie. 2024;357(10). doi:10.1002/ardp.202400192

BibTeX
@article{Shi2024,
  author = {Shi, Zezhou and Zhou, Min and Zhai, Jingfang and Sun, Jie and Wang, Xiaojing},
  title = {Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis},
  journal = {Archiv der Pharmazie},
  year = {2024},
  volume = {357},
  number = {10},
  doi = {10.1002/ardp.202400192}
}
Kostenlos starten →